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Abstract
Structure analysis of the cell-penetrating peptide transportan 10 (TP10) revealed an exemplary range of different
conformations in the membrane-bound state. The bipartite peptide (derived N-terminally from galanin and C-terminally
from mastoparan) was found to exhibit prominent characteristics of (i) amphiphilic a-helices, (ii) intrinsically disordered
peptides, as well as (iii) b-pleated amyloid fibrils, and these conformational states become interconverted as a function of
concentration. We used a complementary approach of solid-state 19F-NMR and circular dichroism in oriented membrane
samples to characterize the structural and dynamical behaviour of TP10 in its monomeric and aggregated forms. Nine
different positions in the peptide were selectively substituted with either the L- or D-enantiomer of 3-(trifluoromethyl)-
bicyclopent-[1.1.1]-1-ylglycine (CF3-Bpg) as a reporter group for
19F-NMR. Using the L-epimeric analogs, a comprehensive
three-dimensional structure analysis was carried out in lipid bilayers at low peptide concentration, where TP10 is
monomeric. While the N-terminal region is flexible and intrinsically unstructured within the plane of the lipid bilayer, the C-
terminal a-helix is embedded in the membrane with an oblique tilt angle of ,55u and in accordance with its amphiphilic
profile. Incorporation of the sterically obstructive D-CF3-Bpg reporter group into the helical region leads to a local unfolding
of the membrane-bound peptide. At high concentration, these helix-destabilizing C-terminal substitutions promote
aggregation into immobile b-sheets, which resemble amyloid fibrils. On the other hand, the obstructive D-CF3-Bpg
substitutions can be accommodated in the flexible N-terminus of TP10 where they do not promote aggregation at high
concentration. The cross-talk between the two regions of TP10 thus exerts a delicate balance on its conformational switch,
as the presence of the a-helix counteracts the tendency of the unfolded N-terminus to self-assemble into b-pleated fibrils.
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Introduction
Membrane-active peptides are often used as cell-penetrating
carriers and antimicrobial agents, but their actual structural
behavior in the membrane-bound state remains elusive and makes
rational design difficult. Interactions with the lipid bilayer tend to
induce specific peptide conformations or trigger structural
changes, such as folding, oligomerization, or aggregation into
amyloid-like fibrils. Here, we have characterized a representative
cell-penetrating peptide, transportan 10 (TP10), and observed a
remarkable structural complexity and conformational equilibrium.
The detailed insights gained into the stabilities and interconver-
sions of its a-helical, unfolded and b-pleated states reveal some
general principles on peptide folding and aggregation in mem-
branes.
Cell-penetrating peptides (CPPs) are used to deliver hydrophilic
cargo into cells without disrupting the plasma membrane [1–6].
Different classes of CPPs have been described, such as the
arginine-rich transporters represented by oligo-arginine and the
well-known TAT peptide [7,8] on the one hand, or the cationic
amphiphilic peptides exemplified by penetratin [2,6,9–11] and the
transportan family [12–16] on the other hand. CPPs differ in their
mechanism of uptake, as transportan peptides tend to be more
membrane-perturbing than arginine-rich ones [17,18]. In fact,
transportan shares many characteristics with pore-forming a-
helical antimicrobial peptides and toxins, such as magainin 2 and
melittin [19–22]. Given their structural similarities, some CPPs
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have been shown to act like antimicrobial peptides, and vice versa
[19,23–27]. Another notable feature of many man-made peptides
is their tendency to aggregate at high concentration [28,29], a
characteristic shared with natural fibril-forming peptides such as
the toxic Ab peptide [30–34], a-synuclein [35,36], IAPP [37], or
calcitonin [38]. In many of these systems, aggregation is surface-
induced or at least enhanced upon binding to lipid membranes
[28–30,32,35–37,39,40].
Peptides are often classified as cell penetrating, membrane
permeabilizing, lytic or fusogenic, and all of them induce some
kind of perturbation in the lipid bilayer. It is generally not possible
to correlate either of these events with any particular peptide
structure, as many peptides (i) are multifunctional [23,25–27,41],
(ii) have non-trivial membrane-bound conformations [42], and (iii)
can interconvert between several different structures [43]. Here,
we set out to understand the diverse ways how a single
representative peptide can interact with membranes. Such a
comprehensive view on the conformational transitions and
aggregation behavior should then be highly valuable for the wider
area of membrane-active peptides in general.
We focused on the membrane-bound structures and the
conformational transitions of TP10, a shorter analog of the
original transportan (TP) peptide with reduced toxicity
[4,16,21,22]. This chimeric family consist N-terminally of a
sequence derived from the neuropeptide galanin [44], and C-
terminally of a sequence from the wasp venom, mastoparan
[16,45]. The two parts are linked by an extra Lys residue, and the
hybrid peptides are highly cationic. They have been successfully
used to transport a variety of biologically relevant cargoes into
living cells [4,46], though the detailed steps of internalization are
still controversial. The structure of TP in a membrane-mimetic
environment has been resolved using liquid-state NMR in SDS
micelles and in phospholipid bicelles [12,47]. A well-defined a-
helix is reported for the C-terminal mastoparan part, while the N-
terminal galanin region is more disordered. The hinge between the
two segments is located around Asn15 (equivalent to Asn9 in
TP10). However, this picture neither reveals the interaction with
nor the alignment of the peptide in a planar lipid membrane.
Furthermore, TP has a tendency to aggregate, like many other
cell-penetrating peptides in the membrane-bound state [28,29].
To understand and control the membrane interactions of this
representative cell-penetrating peptide, an analysis of its detailed
conformation and conformational transitions in contact with the
lipid bilayer is required. Such insight is a prerequisite for
optimizing any peptide sequences that are associated with cell
uptake or applied to disrupt membranes.
Our strategy for investigating the membrane-bound peptide is
based on two complementary techniques, namely solid-state NMR
and oriented circular dichroism (OCD) [48–50]. Both methods
make use of macroscopically aligned lipid bilayer samples, in
which the peptide can be studied under quasi-native conditions,
i.e., at ambient temperature, adequate hydration, and with a well-
defined lipid composition and peptide-to-lipid ratio. OCD
provides rapid qualitative information about the conformation
and alignment of the peptide [48], while solid-state NMR can
yield a full structure with quasi-atomic resolution [39,40,49,51–
56]. Especially 19F-NMR analysis of selectively 19F-labeled
peptides is a highly sensitive approach to obtain site-specific
information [39,40,49,51–56], similar to an alanine or cysteine
scan used in molecular genetics. By introducing a single CF3-
labeled amino acid into successive positions along the peptide
backbone, a three-dimensional picture of the molecule in the lipid
bilayer can be obtained. Further information on local and global
peptide dynamics can be extracted from the effects of motional
averaging [39,40,49,51–57]. For several peptides it has already
been possible to describe various concentration-dependent effects,
such as the re-alignment of a-helices [51,58–60] or the aggrega-
tion into b-sheets [39,40], from which mechanistic insights could
be deduced. With a typical length of 10 to 30 amino acids, all
peptides studied so far have exhibited just one type of secondary
structure in any particular membrane-bound state. Interestingly,
we find here that the 21-mer TP10 possesses a distinct bipartite
structure, in which the N- and C-terminal regions adopt different
conformations, and perturbations in these two regions elicit a
differential sensitivity towards aggregation.
The solid-state 19F-NMR approach relies on the designer-made
19F-labeled amino acid 3-(trifluoromethyl)-bicyclopent-[1.1.1]-1-
ylglycine (CF3-Bpg), which has a stiff and sterically restrictive side
chain [52,54,61,62]. The L-enantiomer has been recently
established as a selective NMR label in studies of membrane-
bound peptides with simple a-helical or b-pleated conformations
[40,52,54,63,64]. By incorporating D-amino acids into peptides, it
has furthermore been possible to modulate their ability to
aggregate as b-sheets [39,65,66]. Now that 19F-NMR has been
established as a reliable method, it is possible to address the
bipartite structure and complex conformational transitions of the
functionally interesting peptide TP10 in detail. This example
shows for the first time how a hybrid peptide is embedded in a
membrane with two different conformational elements, and how a
local destabilization in the a-helical region promotes extensive
aggregation into b-sheeted amyloid-like fibrils. By incorporating
the sterically constrained CF3-Bpg into specific regions of TP10,
we could thus observe and control its conformational transitions.
Materials and Methods
Materials
All amino acids were purchased from Novabiochem (La¨ufelfin-
gen, Switzerland) or IRIS Biotech (Marktredwitz, Germany), and
the coupling reagents 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethy-
luroniumhexafluorophosphate (HBTU) and 1-hydroxybenzo-tria-
zol (HOBt) from Biosolve (Valkenswaard, Netherlands). The 19F-
labeled amino acid CF3-Bpg was prepared in the enantiomerically
pure L- and D-forms by Enamine Ltd. (Kyiv, Ukraine). The lipids
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-
dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPG) were
obtained from Avanti Polar Lipids (Alabaster, AL, USA). RPMI
1640 and fetal calf serum (FCS) were from PAN Biotech
(Aidenbach, Germany).
Solid-phase Peptide Synthesis
All peptides were synthesized on an automated Syro II multiple
peptide synthesizer (MultiSynTech, Witten, Germany) with
standard Fmoc solid-phase peptide synthesis protocols [67] and
HOBt/HBTU as coupling reagents. The 19F-labeled amino acid
CF3-Bpg (see Scheme S1 in File S1) was coupled manually for 2 h
as previously described [40]. The peptides were cleaved off the
resin using a mixture of trifluoroacetic acid (TFA) (93.5%),
triisopropylsilane (TIS) (4%) and H2O (2.5%), precipitated with
diethyl ether and lyophilized. The crude peptides were purified by
high-performance liquid chromatography (HPLC) on a prepara-
tive C18 column (22 mm6250 mm) (Vydac, Hesperia, CA, USA)
using acetonitrile water gradients supplemented with 5 mM HCl.
The identity of all peptides was confirmed by mass spectrometry.
The purity of the peptides was found to be over 95%.
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Carboxyfluorescein (CF)-labeling of Peptides
Peptides were N-terminally coupled to CF before being cleaved
off the resin. Diisopropylcarbodiimide, HOBt and 5(6)-CF in a
molar ratio of 1:1:1 were dissolved in dimethylformamide (DMF),
mixed with the peptide on the resin in a molar ratio of 5:1, and
coupled for 12 h. After washing with DMF, dichloromethane
(DCM), methanol (MeOH) and diethyl ether, piperidine (20% v/v
in DMF) was added for 30 min. Afterwards the resin was washed
with DMF, DCM and MeOH, dried under reduced pressure, and
the peptide was cleaved off the resin and purified using HPLC.
Cell Uptake Assay with Fluorescence Microscopy
HeLa cells were maintained in RPMI 1640 supplemented with
10% FCS, and incubated at 37uC in a 5% CO2-containing
humidified incubator. Cells were passaged every 2 to 3 days. The
concentrations of the CF-labeled peptides were determined by
measuring A492 in Tris-HCl buffer (pH 8.8), assuming a molar
extinction coefficient of 75,000 M21 cm21. Confocal laser scan-
ning microscopy was performed on a TCS SP5 confocal
microscope (Leica Microsystems, Mannheim, Germany) equipped
with an HCX PL APO 636N.A. 1.2 water immersion lens. HeLa
cells were maintained at 37uC on a temperature-controlled
microscope stage. The cells were seeded at a density of
10,000 cells/well three days before the experiment in 8-well
microscopy chambers (Nunc, Wiesbaden, Germany) and grown to
75% confluence. Cells were incubated with 2 or 10 mM of the CF-
labeled TP10 wild type (WT) or the analogs in RPMI 1640
supplemented with 10% FCS for 30 min at 37uC. Cells were
washed twice after the incubation, and living cells were analyzed
immediately by confocal microscopy.
Circular Dichroism Spectroscopy
Circular dichroism (CD) experiments were performed on a J-
815 spectropolarimeter (Jasco, Tokyo, Japan) over the range from
260 to 180 nm at 0.1 nm intervals, using a quartz glass cuvette of
1 mm optical path length (Suprasil, Hellma Optik, Jena,
Germany). The spectra were recorded using a scan rate of
10 nm/min, 8 s response time and 1 nm bandwidth. Three scans
were averaged and the baseline spectrum of pure lipids was
subtracted. The spectra of the peptides in the presence of lipids
were recorded at 30uC (i.e. above the lipid phase transition
temperature). The appropriate amounts of peptides were dissolved
in phosphate buffer (10 mM, pH 7) to yield a stock solution with a
concentration of 0.5 mg/ml. Appropriate amounts of DMPC and
DMPG in a molar ratio of 3:1 were co-dissolved in CHCl3/
MeOH, dried in a stream of nitrogen followed by drying overnight
under reduced pressure, and suspended in 10 mM phosphate
buffer, pH 7.0. The lipid dispersion was homogenized by
vigorously vortexing for 1061 min and by 10 freeze-thaw cycles.
Afterwards, small unilamellar vesicles (SUVs) were generated by
sonication of the multilamellar vesicles for 1 min in a strong
ultrasonic bath (UTR 200, Hielscher, Germany). The sonication
procedure was repeated 4 times, after cooling the water of the
ultrasonic bath down to room temperature with ice, to avoid
overheating of the samples. Three different peptide-to-lipid molar
ratios (P/L= 1:50, 1:100, 1:200) were tested with a lipid
concentration of 1.5 mg/ml and corresponding peptide concen-
trations of 0.1 mg/ml for P/L of 1:50, 0.05 mg/ml for a P/L of
1:100, and 0.025 mg/ml for a P/L of 1:200.
For secondary structure analysis of TP10, the CD spectrum of
the WT peptide at a P/L= 1:50 in DMPC/DMPG vesicles (see
Figure S1 A/B in File S1) was converted to mean residue
ellipticities by using the weighed-in peptide amount and the
volume of the sample for concentration determination. A reliable
UV concentration determination at 280 nm from the absorption
of the single Tyr residue contained in the sequence was not
possible due to the low absorption values and strong background
scattering in the final vesicle sample used for CD. Secondary
structure analyses were performed using three different algorithms:
the CDSSTR program with the implemented SVD (singular value
decomposition) algorithm [68,69], the CONTIN-LL program,
which is based on the ridge regression algorithm [70,71] and the
SELCON-3 program, which incorporates the self-consistent
method together with the SVD algorithm to assign protein
secondary structure [72,73]. The three algorithms as well as the
used protein CD spectra reference data set #7 are provided by the
DICHROWEB on-line server [74,75]. The quality of the fit
between experimental and back-calculated spectrum correspond-
ing to the derived secondary structure fractions was assessed from
the normalized root mean square deviation (NRMSD), with a
value ,0.1 (CONTIN-LL, CDSSTR) and ,0.25 (SELCON-3)
considered as a good fit [75].
Oriented Circular Dichroism Spectroscopy (OCD)
OCD experiments on macroscopically oriented samples were
performed with a designated OCD sample holder built in-house
[48]. Lipids were dissolved in CHCl3 and peptides in MeOH,
appropriate amounts mixed and spread onto a 12 mm diameter
quartz glass plate. The final amount of peptide deposited on a
quartz glass plate was 7.561026 mmol, and the amount of lipid
was adjusted to obtain desired P/L. After drying under reduced
pressure, the samples were hydrated over night at 40uC in 96–97%
relative humidity. The spectra were recorded in the range from
260 to 180 nm using a scan rate of 20 nm/min, 8 s response time,
1 nm bandwidth, at eight different rotations of the cell, and
referenced by subtracting the background signal that was recorded
with a sample containing the same amount of lipids without
peptides.
Solid-state 19F-NMR Spectroscopy
All experiments were performed on a Bruker Avance 500 MHz
NMR spectrometer (Bruker BioSpin, Rheinstetten, Germany) at
40uC. 31P-NMR spectra were acquired at a frequency of
202.5 MHz using a Hahn echo sequence [76] with a 90u pulse
of 5 ms, 30 ms echo time, a sweep width of 200 kHz, 4096 data
points and 28 kHz proton decoupling with SPINAL64 [77] or
TPPM [78]. Usually 128 scans were recorded with a relaxation
delay of 1 s. 19F-NMR was performed at a frequency of
470.6 MHz using an anti-ringing sequence [79] with a 90u pulse
of 3.25 ms, a sweep width of 500 kHz, 4096 data points, and
24 kHz proton decoupling with SPINAL64. Usually, depending
on the amount of peptide, between 2,000 (560 mg peptide, P/
L= 1:50) and 20,000 (130 mg peptide, P/L= 1:400) scans were
acquired with a relaxation delay of 1 s.
For preparing the oriented NMR samples, 14–15 mg (8 mg for
a P/L of 1:50) of a DMPC/DMPG mixture in a molar ratio of 3:1
were dissolved in chloroform and an appropriate amount of
peptide depending on the P/L (560 mg for P/L= 1:50, 260 mg for
P/L= 1:200 and 130 mg for P/L=1:400) was dissolved in MeOH.
Both solutions were thoroughly mixed and equally distributed on
18 glass plates (15 mm67.5 mm60.08 mm) (Marienfeld Labora-
tory Glassware, Lauda-Ko¨nigshofen, Germany). The glass plates
were stacked and hydrated at 48uC in 96% relative humidity for
24 h after drying overnight under reduced pressure. The hydrated
samples were wrapped in parafilm and plastic foil before the NMR
experiments.
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NMR Structure Analysis
The orientation of the peptide in the bilayer was calculated
based on the experimentally determined dipolar couplings (within
the experimental error of 0.5 kHz) of the CF3-Bpg labeled TP10
analogs. According to our CD analysis, the backbone was modeled
as an ideal a-helix. The alignment of the helix in a bilayer is
described by the tilt angle (t) with respect to the membrane
normal, and by the azimuthal rotation angle (r) around the helix.
The overall effect of motional averaging is taken into account by
the Gaussian distribution parameters st and sr as previously
described [57]. The orientation of the Ca2Cb bond vector of the
19F-labeled side chain is described by the angles a=121.1u and
b=53.2u [59]. The orientational parameters t, r, st and sr were
determined by a least-squares fit. The sum of squared deviations to
the experimentally determined dipolar couplings was minimized to
find the best-fit parameters.
Transmission Electron Microscopy (TEM)
The peptides were dissolved in water in a concentration of
2 mM in the absence of lipids. The peptide solution was sprayed
on the carbon-coated grids and subsequently stained with uranyl
acetate (5% aqueous solution with 30% ethanol) to enhance the
contrast. Transmission electron microscopy was performed with a
ZEISS 922 microscope at 200 keV electron energy with an in-
column Omega filter. The images were taken in the bright-field
mode applying zero-loss filtering for contrast enhancement.
Results
To resolve the structural details and study the aggregation
behavior of TP10 in the membrane-bound state, a single 19F-
NMR reporter group was introduced in the peptide sequence as
an L- or D-enantiomer of CF3-Bpg at position Gly2, Leu4, Leu5,
Ile8, Leu10, Leu13, Leu16, Ile20, or Leu21. All analogs were also
synthesized with a CF-label, yielding a total of 36 analogs (L-
epimers are shown in Table S1 in File S1). The influence of the
19F-labeled amino acid on the secondary structure of the peptide
was examined by circular dichroism (CD) spectroscopy in solution,
and the influence on the biological cell uptake activity was assessed
with another set of carboxyfluorescein-19F-labeled analogs using
fluorescence microscopy on HeLa cells. We then analyzed the L-
epimers using solid-state 19F-NMR to determine the conformation
and orientation of monomeric TP10 at low peptide concentration
in oriented DMPC/DMPG (3:1) bilayers. Thereafter, the D-
epimers were measured by 19F-NMR and OCD at high peptide
concentration to examine their aggregation behavior. The
morphology of the TP10 aggregates was characterized by
transmission electron microscopy (TEM).
Characterization of the 19F-labeled TP10 Analogs by CD
and Cell Uptake Assays
To examine the influence of 19F-labeling on the secondary
structure of TP10, we studied the (WT) peptide and the 18 CF3-
Bpg labeled analogs by CD spectroscopy in solution. The peptide
was added to small unilamellar lipid vesicles composed of DMPC/
DMPG (molar ratio of 3:1) at three different peptide-to-lipid molar
ratios (P/L), namely 1:50, 1:100 and 1:200. In these freshly
prepared samples, all TP10 analogs have an a-helical conforma-
tion similar to the WT peptide at all concentrations tested. CD
spectra with a P/L of 1:200 are shown in Figure 1A and 1B for the
L- and D-epimers, respectively. (Data on P/L of 1:50 and 1:100
are presented in Figure S1 in File S1). The L-epimers showed no
signs of perturbation, neither when the label was incorporated in
the N-terminal galanin part, which is colored in green in this and
subsequent figures (including residue Ile8, as will become obvious
from the data below), nor in the C-terminal mastoparan part
(colored in red). We may thus conclude that the TP10 analogs
labeled with L-CF3-Bpg are essentially unperturbed and can be
used for the subsequent 19F-NMR structure analysis. Rough
secondary structure estimation for the WT peptide by deconvolu-
tion of the CD data revealed a helix fraction of around 56%, as
shown in Table 1. This corresponds to a stretch of 12 amino acids
that are helically folded, while the remaining part of the sequence
is predominantly disordered.
The D-epimers showed slight deviations from the WT
spectrum, especially when the CF3-Bpg label was incorporated
in the C-terminal mastoparan region (see red lines in Figure 1B,
and in Figures S1B, S1D, and S2B in File S1). It is not surprising
that the configuration of D-CF3-Bpg leads to moderate structural
perturbations due to the inversion of the natural stereochemistry at
the backbone.
The additional set of 18 N-terminal carboxyfluorescein-19F-
labeled TP10 analogs that were prepared for the cell uptake
experiments were also characterized by CD, giving essentially the
same lineshapes as without the fluorophore (spectra are presented
in Figure S2 in File S1). We note already at this point that also the
19F-NMR spectra of the L-CF3-Bpg labeled peptides with and
without carboxyfluorescein showed no significant differences
(Figure S3 and Table S2 in File S1), so the fluorescent analogs
prepared for the cell-uptake assays can be assumed to represent
those used in the structure analysis.
The cell uptake of the carboxyfluorescein-labeled L-CF3-Bpg
TP10 analogs was investigated by confocal fluorescence micros-
copy and compared to the WT peptide. The fluorescence was
predominantly localized in punctate structures in the cytoplasm of
HeLa cells after incubation for 30 min at 37uC (Figure 2 and
Figure S4 in File S1). Since all L-epimers of TP10 showed an
activity similar to the WT, they are functionally active and suitable
for the subsequent 19F-NMR structure analysis.
Structure Analysis of Monomeric TP10, based on the L-
epimers at Low Peptide Concentration
To determine the three-dimensional structure of membrane-
bound TP10, we carried out solid-state 19F-NMR experiments in
oriented DMPC/DMPG (3:1) bilayers. The L-epimeric peptides
were used for this analysis, as L-CF3-Bpg has the same
configuration as natural amino acids. This side chain does not
usually perturb the peptide conformation when substituted for a
bulky hydrophobic residue, as in the case of the labeled positions
Leu4, Leu5, Ile8, Leu10, Leu13, Leu16, Ile20, and Leu21, (plus
another label at Gly2). The structural compatibility of L-CF3-Bpg
has been demonstrated above by CD, and was previously shown
also for other membrane-active peptides [40,52]. For the NMR
structure analysis we first had to determine and stay below the
concentration threshold at which the L-epimeric TP10 analogs
would start to aggregate. The unique sensitivity of 19F-NMR
makes it possible to detect even very low peptide concentrations
[49,56,80], allowing us to readily screen P/L ratios of 1:50, 1:200,
and 1:400 (Figure 3A). Only at 1:400 did we obtain sharp 19F-
NMR spectra with no signs of aggregation (as explained below) for
all TP10 L-epimers (Figure 3C), even after prolonged sample
storage. Under these conditions also the 31P-NMR spectra of the
phospholipids confirmed a high quality in terms of the degree of
lipid orientation in the samples before and after the 19F-NMR
measurements, with around 85% of the lipids being well-oriented
(Figure 3B).
The structure analysis was thus carried out at P/L=1:400,
where the well-resolved 19F-NMR spectra yielded distinct dipolar
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splittings, and where all 19F-labeled analogs can be safely assumed
to reflect the monomeric structure of TP10. The absence of
aggregation could be further confirmed by showing that the
peptides are mobile on the millisecond timescale of the NMR
experiment due to free rotational diffusion in the bilayer plane
[39,49,52,56]. To examine mobility, each oriented sample was
measured twice: with the bilayer normal aligned parallel (0u) and
perpendicular (90u) to the direction of the external magnetic field
B0. As the dipolar splittings at 0u were found to be scaled by a
factor of 21/2 upon changing the orientation to 90u, this means
that the peptides are engaged in fast rotation around the bilayer
normal, which is indicative of monomers or very small oligomers
at most [39,40,49,56]. The NMR data of all TP10 L-epimers
showed this behavior at low peptide concentration (P/L= 1:400),
confirming that no aggregation had taken place. In some of the
NMR spectra at higher peptide concentration (P/L= 1:50) an
emerging powder pattern suggested the onset of immobilization.
Yet, even in those cases the sharp dipolar couplings of the mobile
component did not change with peptide concentration (Figure S5
and Table S3 in File S1). It can thus be concluded that TP10 has a
well-defined structure at low concentration and does not undergo
any concentration-dependent re-alignment or gradual conforma-
tional change before the onset of aggregation. All NMR spectra at
P/L=1:50 and 1:200 are given in Supporting Information (Figure
S5 in File S1), and the dipolar couplings at P/L= 1:50 and 1:200
are listed in Table S3 in File S1.
The well-resolved dipolar splittings of the CF3-groups in the
nine L-epimers were used as orientational constraints to calculate
the three-dimensional structure of monomeric TP10 in the
membrane. Details of the corresponding dipolar wave analysis
have been described elsewhere [39,55,81,82]. Briefly, if a regular
secondary structure such as an a-helix can be presumed, a least-
squares fit will yield the helix tilt angle (t) and the azimuthal
rotation angle (r), plus the mobility parameters st and sr. In the
case of TP10, there is ample evidence for an a-helical
conformation, based on the CD analysis above and on the
liquid-state 1H-NMR structure of the parent peptide transportan
[12,13,47]. However, when we attempted to fit the data of all nine
L-CF3-Bpg labels to a straight a-helix, this led to an insufficient
quality of the fit with a very large root-mean-square deviation
(RMSD) (Figures 4A and 4B). On the other hand, it is known that
the NMR structure of transportan in SDS micelles and
phospholipid bicelles has a kink around Asn15 (equivalent to
Asn9 in TP10) and a more flexible N-terminus [12,13]. Therefore,
assuming an helical structure as evidenced by CD spectroscopy,
we carried out a segmental analysis of the individual N- and C-
terminal parts separately and obtained a very good fit for the C-
terminal region with a low RMSD (Figures 4C and 4D).
These data suggest that the C-terminal region of TP10, which
was derived from mastoparan, has a well-defined a-helical fold in
the membrane-bound state. This finding supports our observation
by CD that membrane-bound TP exhibits roughly 56% helicity
(Table 1), which would corresponds well to the 12 C-terminal
residues. Based on the dipolar couplings of the labeled positions
Leu10, Leu13, Leu16, Ile20, and Leu21, the data analysis yielded
a helix tilt angle of t<55u and an azimuthal rotation angle of
Table 1. Secondary structure of TP10-WT bound to DMPC/DMPG vesicles evaluated from the CD spectrum (P/L = 1:50, see Figure
S1 A/B in File S1 for details).
Algorithm Fraction of secondary structure NRMSDa
a-helix b-strand Turn Unordered
CONTIN-LL 0.58 0.06 0.12 0.24 0.088
CDSSTR 0.59 0.13 0.12 0.16 0.005
SELCON-3 0.52 0.08 0.17 0.24 0.172
aNRMSD=normalized root mean square deviation between calculated and experimental CD spectra.
doi:10.1371/journal.pone.0099653.t001
Figure 1. CD spectra of the CF3-Bpg labeled TP10 analogs. CD spectra are recorded in the presence of unilamellar DMPC/DMPG (3:1) vesicles
at a P/L ratio of 1:200. (A) L-epimers and (B) D-epimers are compared with the WT peptide (black line). Analogs with CF3-Bpg in the galanin part are
represented by green lines and in the mastoparan part by red lines.
doi:10.1371/journal.pone.0099653.g001
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r<120u, with a moderate wobble (sr) around the long axis. The
alignment of the a-helix in the lipid bilayer is illustrated in
Figure 5A. The obtained azimuthal rotation angle is in full
agreement with the amphiphilic character of the helix. The helical
wheel projection of the membrane-embedded C-terminal region
in Figure 5B shows that the hydrophobic residues face the bilayer
interior, while the positively charged Lys residues point towards
the aqueous layer.
In contrast, the dipolar splittings of the N-terminal part of TP10
could not be fitted to an a-helix, or to any other regular secondary
structure element. Instead, all dipolar couplings of the N-terminal
labels (positions Gly2, Leu4, Leu5, Ile8) are close to +7 kHz, a
value that has been reported as characteristic for a unstructured
peptide backbone that is swimming around flexibly in the
membrane [40]. A previous study on isolated galanin peptides
had also shown that this glycine-rich sequence is largely
unstructured in various environments, including lipid bilayers
and detergent micelles [83]. We can thus refer to the galanin-
derived segment of TP10 as a region of the peptide that is
intrinsically unstructured within the two-dimensional membrane
plane - analogous to the concept of intrinsically unstructured
proteins in aqueous solution [84,85]. We thus conclude that the
galanin-derived N-terminus of TP10 is essentially unstructured
within the 2D plane of the membrane, while being anchored to the
bilayer surface by its hydrophobic residues. The detailed structure
derived here by 19F-NMR is good agreement with the qualitative
picture obtained above by CD lineshape deconvolution (see
Table 1), for which the estimated 56% helical fold can be
attributed now to the C-terminal mastoparan-derived segment.
Analysis of the Aggregation Behavior of TP10, based on
the D-epimers
Next, the dipolar splittings were measured for the series of TP10
epimers labeled with D-CF3-Bpg, where the Ca configuration is
stereochemically inverted. At a low peptide concentration of P/
L= 1:400, the splittings along the entire sequence are all rather
close to +7 kHz (Table S4 in File S1). The C-terminal part of
TP10 can clearly no longer be fitted to an a-helix. Instead, the
characteristic range of dipolar splittings suggests that the helix has
now become unfolded within the plane of the membrane, just like
the N-terminus. It thus appears that the introduction of a single
bulky D-CF3-Bpg residue in the C-terminal segment leads to local
destabilization around the D-amino acid and possibly of the entire
a-helical part. On the other hand, incorporation of D-CF3-Bpg in
Figure 2. Cellular uptake of TP10. (A, B) Internalization of TP10 WT and of two representative 19F-labeled analogs Ile8R L-CF3-Bpg (C), and
Ile20R L-CF3-Bpg (D) by HeLa cells. The cells were incubated with 10 mM peptide at 37uC for 30 min.
doi:10.1371/journal.pone.0099653.g002
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the N-terminal region does not have any significant structural
consequences, as this part of the peptide is intrinsically flexible
anyway.
Having found that D-CF3-Bpg destabilizes the helical region of
TP10 and leads to unfolding in the membrane at low concentra-
tion, we also examined the D-epimers at a high P/L ratio of 1:50.
The 19F-NMR spectra of freshly prepared samples are shown in
Figure 6, and the splittings are listed in Table S4 in File S1. It
appears that all analogs with D-substituents in the C-terminal
region of TP10 (at positions Leu13, Leu16, Ile20, or Leu21) are
partly or completely aggregated. This is seen from the static
powder components in the lineshapes, with dipolar splittings of28
kHz (as illustrated by the boxes in Figure 6). Upon changing the
sample alignment from 0u to 90u these splittings are no longer
reduced by a factor of 21/2, which is a sign that the peptide
molecules are completely immobilized. On the other hand,
introduction of D-CF3-Bpg into the N-terminal region of TP10
(at position Gly2, Leu4, Leu5, Ile8, or Leu10) did not lead to
aggregation. In these cases, all dipolar splittings remained close to
+7 kHz as seen for P/L= 1:400, and they were reduced by a factor
of 21/2 when the sample alignment was changed from 0u to 90u
(see Figure 6, and Table S4 in File S1). It may thus be concluded
that a destabilization of the a-helical mastoparan part of TP10 by
the sterically restrictive D-CF3-Bpg leads to unfolding at low
peptide concentration and an enhanced aggregation at high
concentration.
Strictly speaking, the appearance of a static 19F-NMR powder
pattern does not prove aggregation per se, but it shows that the
molecules are no longer well-oriented in the membrane and are
immobilized on the millisecond time-scale of the NMR experi-
ment. It is impossible to deduce any structural parameters from
these powder spectra, because all orientational order has been lost.
Figure 3. Solid-state NMR spectra of TP10: (A) 19F-NMR spectra of TP10 labeled with L-CF3-Bpg at Ile8, recorded at three different peptide-to-
lipid molar ratios (P/L = 1:50, 1:200, and 1:400) in oriented DMPC/DMPG (3:1) bilayers. The hydrated membrane samples were aligned with their
normal parallel (0u) and perpendicular (90u) to the static magnetic field B0 (indicated by an arrow). (B) Solid-state
31P-NMR spectra of the same
samples as in (A), recorded before and after the corresponding 19F-NMR experiment, showing a high quality of lipid alignment. (C) Solid-state 19F-
NMR spectra of the nine L-CF3-Bpg labeled TP10 analogs at P/L = 1:400, from which the dipolar couplings of the CF3-groups were obtained for the
structure calculation. All experiments were performed at 40uC.
doi:10.1371/journal.pone.0099653.g003
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We thus wanted to find out whether the immobilized peptides (P/
L= 1:50 positions Leu10, Leu13, Leu16, IIe20, Leu21 in Table S4
in File S1) have taken on a characteristic b-sheet conformation, as
often implied for aggregation and amyloid formation. To this aim,
we employed oriented circular dichroism (OCD) to determine the
conformation of the TP10 analogs in the same type of oriented
Figure 4. NMR structure analysis of TP10. Dipolar wave analysis of the 19F-NMR dipolar couplings of monomeric TP10 in hydrated membranes
(DMPC/DMPG, P/L = 1:400). It is not possible to fit all nine L-CF3-Bpg labels to a continuous a-helix (A), as a poor fit with a high RMSD would be
obtained (B). A fit of the five C-terminal labels (C, red) produces a good result with a low RMSD (different color scale compared to B) (D). The
alignment of the C-terminal a-helix is described by a tilt angle t<55u and an azimuthal rotation angle r<120u, with a moderate wobble (sr) around
the long axis. The black region of the plot shows the possible range of t and r with the same RMSD. The N-terminal region of TP10 is intrinsically
unstructured in the plane of the membrane, as seen from the characteristic uniform dipolar splittings of around +7 kHz (C, green).
doi:10.1371/journal.pone.0099653.g004
Figure 5. Membrane-bound structure of TP10, as derived by solid-state 19F-NMR. (A) The N-terminal region is intrinsically unstructured
(green) and connected to the C-terminal a-helix (red). The amphiphilic helix is embedded in the lipid membrane with a tilt angle of t<55u and an
azimuthal rotation angle of r<120u. (B) The helical wheel projection of the C-terminal mastoparan part illustrates how the charged Lys residues (grey)
point towards the aqueous phase, while the hydrophobic residues (yellow) face the interior of the membrane. The yellow box represents the bilayer
(not drawn to scale, and without implying any particular insertion depth of the peptide within the bilayer).
doi:10.1371/journal.pone.0099653.g005
Membrane-Bound Structure of TP-10
PLOS ONE | www.plosone.org 8 June 2014 | Volume 9 | Issue 6 | e99653
DMPC/DMPG (3:1) samples and at the same P/L ratio of 1:50 as
in 19F-NMR. To pick up any slow kinetics of aggregation, ageing
studies were performed over 1, 5 and 8 days of incubation at 48uC
under a fully hydrated atmosphere, yielding the characteristic
OCD spectra illustrated in Figure 7. The complete set of OCD
spectra for the WT peptide and all the D-epimers is presented in
Figure S6 in File S1. The observed decrease in spectral intensity
with time is attributed to lateral phase segregation of the
membrane-bound helical peptides into peptide-rich domains,
which reduces the intensity of the CD signal.
OCD analysis demonstrated that all TP10 analogs with a D-
CF3-Bpg substitution in the C-terminal region gave typical b-sheet
lineshapes (Figure 7B). On the other hand, substitutions in the N-
terminal part had no impact on the predominantly a-helical
conformation of the D-epimeric peptides (Figure 7A), which
behaved like the TP10 WT. We thus conclude that incorporation
of the bulky D-amino acid into the flexible N-terminal region did
not disturb the peptide structure and preserved the folded helical
C-terminus. In contrast, D-CF3-Bpg in the C-terminal region led
to an unfolding of the helix and made the peptide more disordered
at low concentration, which permitted its aggregation at higher
concentration into b-sheets. Overall, we have thus identified by
OCD the same pattern of aggregation as seen by solid-state 19F-
NMR under the same conditions in the same type of samples.
Transportan, like many other membrane-active peptides, has a
known tendency to aggregate at high concentration [28,29,32,35–
37]. In the case of TP10, we recall that several L-epimeric TP10
analogs had already shown signs of aggregation at P/L= 1:50 in
fresh 19F-NMR samples (Figure S5 in File S1). The aggregation
process is typically surface-induced and accelerated in the
membrane-bound state as reported for various systems [35,86–
88], where all peptide molecules are confined within the two-
dimensional plane of the bilayer with an increased local
concentration. Aggregation is often associated with the transition
of an intrinsically unstructured peptide into oligomeric b-sheets in
a concentration and time dependent manner. We have recently
used the model peptide [KIGAKI]3 to examine this process and
characterize its typical 19F-NMR signature [40,89]. Self-assembly
of this system in membranes [40,66] leads to formation of fibrils
that are similar to amyloid consisting of hydrogen-bonded cross-b-
strands [32–34,36,90].
It is intrinsically difficult to prove the formation of genuine
amyloid fibrils in the presence of membranes. For example, the
thioflavin-T assay does not work, because the positive charge on
the thioflavin-T micelles interferes with binding to the cationic
peptides due to electrostatic repulsion [91]. Electron microscopy in
the presence of membranes is problematic, too, because mixtures
of lipids with self-assembling peptides can give rise to unusual
morphologies in which it is hard to discriminate regular fibrils
[92]. Therefore, we decided to use TEM to directly observe the
peptide aggregates in the absence of any lipid. The L- and D-
epimers labeled at position Leu16 were incubated in water at
2 mM concentration at 20uC. After 24 hours the sample with the
L-epimer was opaque and the D-epimer even more so. The
Figure 6. D-amino acid ‘‘scan’’ to identify aggregation-prone regions in TP10. Aggregation of TP10 depends on the position of substitution
with the sterically restrictive D-CF3-Bpg, as monitored by solid-state
19F-NMR and OCD in oriented DMPC/DMPG (3:1) at P/L = 1:50. The boxed spectral
regions show the static powder pattern contributions of immobilized molecules with 28 kHz splittings.
doi:10.1371/journal.pone.0099653.g006
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representative TEM images in Figure 8 reveal a network of short
fibrils in both samples, reminiscent of amyloid fibrils, thus
supporting the OCD observations above (for OCD of L-epimer
see Figure S7 in File S1). Assuming that peptide aggregation is an
intrinsic property of a given sequence and that its immediate
environment influences mainly the kinetics of aggregation but not
the local morphology, it is reasonable to argue that the observed
cross-b-sheet fibrils in the absence of lipids should be similar to
those in the presence of membranes.
Discussion
We have shown that TP10 can assume three distinctly different
conformations in the membrane-bound state (Figure 9). The
monomeric structure has a well-defined a-helix in the C-terminal
region, and a flexible N-terminus that may be regarded as
intrinsically unstructured in the plane of the membrane
(Figure 9A). This picture is consistent with an earlier NMR
analysis in detergent micelles [47], and with a more recent MD
study of TP10 in a POPC bilayer [93]. If the helix is perturbed,
the peptide unfolds completely and starts to aggregate as amyloid-
like fibrils in a concentration and time dependent manner. While
the incorporation of L-CF3-Bpg as a
19F-NMR label does not
significantly perturb the peptide, the sterically obstructive D-
epimer can be used to dramatically shift the transition from the
partially a-helical monomer « unfolded monomer « b-pleated
aggregate. Remarkably, the tendency to aggregate depends
distinctly on the position of the substitution. When D-CF3-Bpg
is incorporated into the intrinsically flexible N-terminal region of
TP10, the peptide maintains its usual partially a-helical structure
(Figure 9B). A substitution in the C-terminal region, on the other
hand, leads to unfolding and subsequent aggregation as b-sheets at
high concentration (Figure 9C).
The effect of D-CF3-Bpg on TP10 resembles the reported
destabilization of the a-helical region in the Ab peptide by D-
amino acids or proline, which subsequently leads to enhanced
aggregation [94]. At the same time - and seemingly contradictory
at first sight - it has been reported that D-amino acids can also be
used to prevent the aggregation of peptides [39,40,89]. This effect
is not attributed to equilibrium between helix and unfolded state
(as in TP10 or Ab), but instead to the self-assembly of already
unfolded peptides (from the b-stranded KIGAKI family) into
aggregated fibrils. The resulting b-sheets are destabilized, because
the sterically obstructive side chain cannot be readily accommo-
Figure 7. OCD spectra of TP10. Representative OCD spectra of TP10 labeled with D-CF3-Bpg in oriented DMPC/DMPG (3:1) bilayers at P/L = 1:50,
measured after 1, 5, and 8 days of ageing. (A) Peptide analogs with a substitution in the N-terminal region (here: position Leu4) have a predominantly
a-helical structure, just like the WT peptide. (B) When D-CF3-Bpg is placed into the C-terminal region (here: position Leu16), the peptide aggregates
with a b-sheet conformation typical of amyloid-like fibrils.
doi:10.1371/journal.pone.0099653.g007
Figure 8. Fibril formation of TP10. TEM images of TP10 analogs (A) Leu16R L-CF3-Bpg, (B) Leu16R D-CF3-Bpg, showing a network of amyloid-
like fibrils.
doi:10.1371/journal.pone.0099653.g008
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dated in the ordered core of the amyloid. In the case of a sensitive
helix-to-sheet equilibrium, the decisive aspect is whether the a-
helix or the b-sheet is more strongly perturbed by the D-amino
acid. Along the same lines, it has been reported that the systematic
replacement of amino acid pairs with D-ProGly could accelerate
Ab fibril formation [95], while pairs of D-amino acids, or even
single proline residues, have been used as amyloid breakers [96]. It
was thus interesting to see that not only the L- but also the D-
epimers of TP10 ended up as amyloid-like fibrils. To reconcile
these observations, it must be noted that b-sheets can actually
tolerate the odd misfit. For example, the b-pleated model peptide
[KIGAKI]3 can assemble as b-sheets even with one third of its
amino acids exchanged to the D-form [65,66], meaning that only
the D-amino acid itself and its closest neighbors are excluded from
the ordered array of hydrogen-bonds in a typical sheet. It is
therefore perfectly reasonable that a bulky D-amino acid can have
both effects, of either preventing or promoting amyloid formation.
The observed outcome depends on the relative destabilization of the
original (a-helical) conformation compared to the resulting b-sheet
structure. In the case of TP10, which already contains an
unstructured N-terminus, the aggregation equilibrium is shifted
to the right when the destabilizing D-CF3-Bpg is incorporated into
the C-terminus. In the Model Amphiphilic Peptide MAP
[KLALKLALKALKAALKLA-NH2], on the other hand, the
equilibrium is shifted to the left and aggregation is prevented by a
D-amino acid. That is because MAP can engage in favorable
interactions with the membrane only as an amphiphilic helix
[39,97]. Likewise, in [KIGAKI]3, bulky D-amino acids shift the
aggregation threshold to higher peptide concentration, as the
unfolded peptide has no reason to become a-helical [40,65,66].
Based on the TEM images and the OCD spectra of aggregated
TP10 with D-CF3-Bpg, which show an essentially complete b-
structure, we expect that the entire peptide may assume a regular
b-sheet conformation in the presence as well as absence of
membranes, apart from the local position that is labeled with D-
CF3-Bpg and its immediate surroundings. There is of course no
indication from our data on the parallel or antiparallel alignment,
or any possible staggering. However, a parallel unstaggered
arrangement as depicted in Figure 9C would minimize the
destabilizing effects of the D-amino acid on the b-sheet and is
therefore most likely. We trust that this picture offers for the first
time an appropriate description of (a) the monomeric structure of
TP10 in a lipid bilayer, and (b) of its possible conformational
switch in the presence of a cellular membrane at high concentra-
tion. To our knowledge this is the first detailed study focusing on
the structure analysis and aggregation propensity of a cell-
penetrating peptide in its functionally relevant membrane-bound
state. TP10 is a truncated derivative of transportan, a designer-
made hybrid that was constructed from an N-terminal galanin
sequence and a C-terminal mastoparan part, as illustrated in
Figure 10. Transportan and several other CPPs have been
Figure 9. Structure and aggregating behavior of TP10. (A)
Monomeric structure of TP10 as determined from 19F-NMR in the
membrane-bound state. The N-terminal galanin-derived region (green)
is intrinsically unstructured, while the mastoparan-derived C-terminus
(red) is folded as an a-helix. (B) When D-CF3-Bpg (black) is introduced
into the flexible region, there is no conformational change. (C) However,
when this stiff D-amino acid is placed into the helical C-terminal region,
it leads to unfolding. At low concentration the monomers remain
unstructured, but at high concentration surface-induced aggregation
leads to the assembly of b-pleated amyloid-like fibrils. These cross-b-
sheet assemblies must be distorted in the immediate vicinity of the D-
amino acid. There is no indication if the b-sheets are parallel or
antiparallel. As the b-sheets have no preferential orientation in the lipid
bilayer (and they may be twisted), they give powder-type NMR spectra.
doi:10.1371/journal.pone.0099653.g009
Figure 10. Structural characteristics of TP10. Summary of features related to the bipartite character of the hybrid peptide TP10 (positions
labeled with CF3-Bpg are marked in red).
doi:10.1371/journal.pone.0099653.g010
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previously characterized in detergent micelles and/or bicelles
[12,47,98,99], but the oriented lipid bilayers used here for solid-
state 19F-NMR and OCD analysis resemble native cell membranes
much more closely. Our comprehensive structure analysis of TP10
has confirmed its intrinsic bipartite character (Figure 10) and
refined the structure of the peptide in genuine lipid bilayers. It is
remarkable to see that the underlying sequences and presumably
the conformational features of the original galanin and masto-
paran building blocks are essentially retained in the hybrid
peptide. TP10 contains a glycine-rich, unstructured flexible N-
terminal region, and a C-terminal a-helix that is obliquely tilted in
the membrane in accordance with its amphiphilic profile (Figure 5).
Besides having resolved the biologically relevant peptide confor-
mation, our results have also yielded the distinct membrane
alignments of the individual peptide segments and explained their
role in aggregation. Being a typical membrane-active peptide, this
structural description of TP10 is relevant for the wide group of
cell-penetrating and antimicrobial peptides in general, and it
contributes also to a better understanding of lipid-induced amyloid
fibril formation.
Supporting Information
File S1 Figure S1, CD spectra of the CF3-Bpg labeled TP10
analogs bound to DMPC/DMPG vesicles. (A) L- and (B) D-
epimers at P/L= 1:50. (C) L- and (D) D-epimers at P/L=1:100.
The wild type TP10 is shown as a black line; green lines show
analogs with CF3-Bpg labels in the galanin part, and red lines in
the mastoparan part. Figure S2, CD spectra of the carboxyfluor-
escein- and CF3-Bpg labeled TP10 analogs in DMPC/DMPG
vesicles at P/L= 1:50. (A) L- and (B) D-epimers. The wild type
TP10 is shown as a black line; green lines show analogs with CF3-
Bpg labels in the galanin part, and red lines in the mastoparan
part. Figure S3, Comparison of the solid-state 19F-NMR spectra of
L-CF3-Bpg labeled TP10. Analogs with and without the carboxy-
fluorescein-label were measured in oriented DMPC/DMPG
bilayers at P/L= :200, at 40uC, with the sample normal aligned
parallel (0u) and perpendicular (90u) to the static magnetic field.
Figure S4, Internalization of the carboxyfluorescein-labeled TP10-
WT and the L- and D-CF3-Bpg analogs by HeLa-cells. The cells
were incubated with 2 mM (left column) and 10 mM (right column)
peptide at 37uC for 30 min. Figure S5, Solid-state 19F-NMR
spectra of the L-CF3-Bpg labeled TP10. Analogs were measured in
oriented DMPC/DMPG bilayers at P/L= 1:50 and 1:200, at
40uC, with the sample normal aligned parallel (0u) and
perpendicular (90u) to the static magnetic field B0. Several spectra
showed an immobilized powder component, as indicated by the
boxes. Figure S6, OCD spectra of the D-CF3-Bpg labeled TP10.
Analogs were measured in oriented DMPC/DMPG bilayers at P/
L= 1:50. Spectra were recorded after 1 (straight lines), 5 (dashed
lines) and 8 days (dotted lines) hydration of the OCD sample.
Figure S7, OCD spectra of the Leu16RL-CF3-Bpg labeled TP10.
Peptide measured in oriented DMPC/DMPG bilayers at P/
L= 1:50. Spectra were recorded after 1 (straight lines), 5 (dashed
lines) and 8 days (dotted lines) hydration of the OCD sample.
Scheme S1, Chemical structure of L-CF3-Bpg (left) and D-CF3-
Bpg (right). Table S1, Sequences and LC-MS characterization of
TP10-WT and the analogues labeled with L-CF3-Bpg and with an
additional carboxyfluorescein (CF). (Equivalent data were ob-
tained for the D-epimers). Table S2, Comparison of the 19F-NMR
dipolar couplings of the L-CF3-Bpg labeled TP10 analogs with and
without the fluorescent carboxyfluorescein label in oriented
DMPC/DMPG bilayers (P/L= 1:200), measured at 0u and 90u
sample tilt. Table S3, Dipolar couplings of the L-CF3-Bpg labeled
TP10 analogs in oriented DMPC/DMPG bilayers, measured at 0u
and 90u sample tilt, at P/L= 1:50, 1:200, and 1:400. Table S4,
Dipolar couplings of the D-CF3-Bpg labeled TP10 analogs in
oriented DMPC/DMPG bilayers, measured at 0u and 90u sample
tilt, at P/L= 1:50, 1:200, and 1:400.
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